MATTHEW JOSEPH

Allopathic & Osteopathic Physicians|Hospitalist NASHVILLE, TN NPI 1013273044

General Payments — all program years on this page

$4,172.87

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 173
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $450.15 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $450.1520

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $768.1332
2019 $1,146.4146
2020 $857.9833
2021 $353.6418
2022 $352.7411
2023 $243.8213
2024 $450.1520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078187839 Janssen Pharmaceuticals, Inc $20.77 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078188083 Janssen Pharmaceuticals, Inc $18.49 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078676081 Janssen Biotech, Inc. $31.00 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089439437 Daiichi Sankyo Inc. $29.20 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093895633 Alexion Pharmaceuticals, Inc. $20.71 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104012588 ABBVIE INC. $18.76 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113857287 PUMA BIOTECHNOLOGY, INC. $22.94 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115987377 GlaxoSmithKline, LLC. $24.34 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117836242 Boehringer Ingelheim Pharmaceuticals, Inc. $22.33 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120244465 EMD Serono, Inc. $19.51 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131718076 PFIZER INC. $18.74 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142962013 Stemline Therapeutics Inc. $23.81 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142962015 Stemline Therapeutics Inc. $18.85 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143482141 Aveo Pharmaceuticals, Inc. $40.80 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144959944 Takeda Pharmaceuticals U.S.A., Inc. $24.63 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144959946 Takeda Pharmaceuticals U.S.A., Inc. $28.28 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153600801 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.13 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153601283 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.42 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153635258 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.67 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154822753 Pharmacosmos Therapeutics Inc. $18.77 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.